Manal F. Abdelmalek

Professor of Medicine

Campus mail: 03119 Hosp South, Suite 03107, Room 03125, Durham, NC 27710

Phone: (919) 684-3262

My research interests include metabolic liver disease, particularly obesity-related liver disease and its association with complications of the insulin resistance syndrome. I am interested in studying the clinical, environmental, and genetic risk factors for nonalcoholic fatty liver disease, new therapeutic options for treatment, and evaluating the impact of NAFLD from a public health perspective.

Education and Training

University Missouri Kansas City, M.D. 1992
Mayo School of Health Sciences, Medical Resident, Medicine
Mayo School of Health Sciences, Fellow in Gastroenterology, Medicine

Selected Grants and Awards

Publications

1148-P: Cenicriviroc Safety in over 1,200 Subjects

1164-P: Effects of Cenicriviroc in Adults with NASH on Inflammatory Cytokines and Metabolic Parameters

136-OR: Efficacy of Cenicriviroc (CVC) in Adults with NASH-Induced Liver Fibrosis

79-year-old woman with blue toes.

A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.

A retrospective chart review of 1065 consecutive liver allograft recipients in 11 centers from January 1997 to September 1998 was performed. Patients were followed for 3 years or until graft loss.

A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.

Post-menopausal women with nonalcoholic steatohepatitis (NASH) are at an increased risk of hepatic fibrosis when compared with premenopausal women.

Manal F. Abdelmalek

Education and Training

Selected Grants and Awards

Publications

1148-P: Cenicriviroc Safety in over 1,200 Subjects

1164-P: Effects of Cenicriviroc in Adults with NASH on Inflammatory Cytokines and Metabolic Parameters

136-OR: Efficacy of Cenicriviroc (CVC) in Adults with NASH-Induced Liver Fibrosis

79-year-old woman with blue toes.

A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.

A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis

A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis

A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.

Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection.

Pages

You are here

Manal F. Abdelmalek

Education and Training

Selected Grants and Awards

Publications

Pages